SBI Securities’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
Other funds holding MRKR
SBI Securities's MRKR Position: Q3 2026 in Review
SBI Securities reduced its Marker Therapeutics (MRKR) stake by 0.49% in Q3 2026, selling an estimated $1 and leaving 202 shares worth $216. The position accounts for ﹤0.01% of the portfolio, ranked #3388.
SBI Securities first reported a position in MRKR in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.61K in Q2 2025. 36 funds tracked by Wall St. Rank hold MRKR as of Q3 2026.
- SBI Securities held 202 shares of Marker Therapeutics worth $216 as of Q3 2026.
- SBI Securities sold 1 Marker Therapeutics share in Q3 2026, an estimated $1.
- Marker Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3388 holding.
- SBI Securities first reported a position in Marker Therapeutics in Q4 2024 and has held it in 8 quarters since.
- SBI Securities's Marker Therapeutics position peaked at $2.61K in Q2 2025.
- 36 funds tracked by Wall St. Rank held Marker Therapeutics as of Q3 2026.
Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.